Literature DB >> 20696872

Affinity of ceftobiprole for penicillin-binding protein 2b in Streptococcus pneumoniae strains with various susceptibilities to penicillin.

Todd A Davies1, Wenping He, Karen Bush, Robert K Flamm.   

Abstract

Wild-type penicillin-binding protein (PBP) 2b from penicillin-susceptible Streptococcus pneumoniae had high affinity for ceftobiprole and penicillin (50% inhibitory concentrations [IC(50)s] of ≤0.15 μg/ml) but not ceftriaxone (IC(50) of >8 μg/ml). In clinical isolates, ceftobiprole and PBP 2b affinities were reduced 15- to 30-fold with a Thr-446-Ala substitution and further still with an additional Ala-619-Gly PBP 2b substitution. Ceftobiprole remained active (MICs of ≤1 μg/ml) against all strains tested and behaved more like penicillin than ceftriaxone with respect to PBP 2b binding.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20696872      PMCID: PMC2944626          DOI: 10.1128/AAC.00590-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

Review 1.  beta-lactam-resistant Streptococcus pneumoniae: epidemiology and evolutionary mechanism.

Authors:  R Hakenbeck
Journal:  Chemotherapy       Date:  1999 Mar-Apr       Impact factor: 2.544

2.  Activities of ceftobiprole and other beta-lactams against Streptococcus pneumoniae clinical isolates from the United States with defined substitutions in penicillin-binding proteins PBP 1a, PBP 2b, and PBP 2x.

Authors:  Todd A Davies; Wenchi Shang; Karen Bush
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

3.  In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci.

Authors:  P Hebeisen; I Heinze-Krauss; P Angehrn; P Hohl; M G Page; R L Then
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

4.  Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococci.

Authors:  Kensuke Nagai; Todd A Davies; Michael R Jacobs; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

5.  Penicillin-binding protein 1A, 2B, and 2X alterations in Canadian isolates of penicillin-resistant Streptococcus pneumoniae.

Authors:  Kimberly A Nichol; George G Zhanel; Daryl J Hoban
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

6.  PBP active site flexibility as the key mechanism for beta-lactam resistance in pneumococci.

Authors:  Carlos Contreras-Martel; Cécile Dahout-Gonzalez; Alexandre Dos Santos Martins; Miha Kotnik; Andréa Dessen
Journal:  J Mol Biol       Date:  2009-02-20       Impact factor: 5.469

7.  Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae.

Authors:  Todd A Davies; Malcolm G P Page; Wenchi Shang; Ted Andrew; Malgosia Kania; Karen Bush
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

8.  Biochemical characterization of Streptococcus pneumoniae penicillin-binding protein 2b and its implication in beta-lactam resistance.

Authors:  Estelle Pagliero; Laurent Chesnel; Julie Hopkins; Jacques Croizé; Otto Dideberg; Thierry Vernet; Anne Marie Di Guilmi
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

9.  Interaction of non-lytic beta-lactams with penicillin-binding proteins in Streptococcus pneumoniae.

Authors:  R Hakenbeck; S Tornette; N F Adkinson
Journal:  J Gen Microbiol       Date:  1987-03

10.  Highly variable penicillin resistance determinants PBP 2x, PBP 2b, and PBP 1a in isolates of two Streptococcus pneumoniae clonal groups, Poland 23F-16 and Poland 6B-20.

Authors:  Radoslaw Izdebski; Jens Rutschmann; Janusz Fiett; Ewa Sadowy; Marek Gniadkowski; Waleria Hryniewicz; Regine Hakenbeck
Journal:  Antimicrob Agents Chemother       Date:  2007-12-26       Impact factor: 5.191

View more
  2 in total

Review 1.  Ceftobiprole medocaril: a review of its use in patients with hospital- or community-acquired pneumonia.

Authors:  Yahiya Y Syed
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

Review 2.  Mechanisms of action and antimicrobial activity of ceftobiprole.

Authors:  M I Morosini; M Díez-Aguilar; R Cantón
Journal:  Rev Esp Quimioter       Date:  2019-09       Impact factor: 1.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.